| Zofenopril |
13383/14.06.2006 |
ZOFEN, Film coated tablet, 7,5 mg, -, Pack: 7 |
Berlin - Chemie AG, Германия |
A.Menarini Manufacturing Logistics and Services S.r.L., Italy |
3.91 |
0.78 |
4.69 |
7% |
0.27 |
4.18 |
0.84 |
5.02 |
20% |
0.78 |
4.96 |
0.99 |
5.95 |
КЦ-49/21,04,2008 г.; НСР-15182/02.03.2018 |
22.05.2008 |
02.04.2018 |
|
|
Заличен |
7930 |
| Zofenopril |
13383/14.06.2006 |
ZOFEN, Film coated tablet, 7,5 mg, -, Pack: 7 |
Berlin - Chemie AG, Германия |
A.Menarini Manufacturing Logistics and Services S.r.L., Italy |
3.91 |
0.78 |
4.69 |
7% |
0.27 |
4.18 |
0.84 |
5.02 |
20% |
0.78 |
4.96 |
0.99 |
5.95 |
КЦ-49/
21,04,2008 г. |
22.05.2008 |
22.05.2008 |
|
|
Неактивен |
7930 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Novartis Pharma GmbH, Германия |
27.83 |
5.57 |
33.4 |
6% |
1.67 |
29.5 |
5.9 |
35.4 |
18% |
5.01 |
34.51 |
6.9 |
41.41 |
НСР-18319/28.03.2019 |
02.05.2019 |
02.05.2019 |
|
|
Активен |
2488 |
| Alprazolam |
ІІ-15496/29,12,2006 |
Zolarem, Tablet, 0,5 mg, -, Pack: 30 |
Ozone Laboratories B.V., Нидерландия |
Aegis Ltd. - Cyprus |
4.6 |
0.92 |
5.52 |
7% |
0.32 |
4.92 |
0.98 |
5.9 |
20% |
0.92 |
5.84 |
1.17 |
7.01 |
КЦ-300/
20,11,2008 г. |
20.01.2009 |
20.01.2009 |
|
|
Активен |
7030 |
| Zoledronic acid |
EU/1/12/800/004 |
Zoledronic Acid Hospira, Solution for infusion, 5 mg/100 ml, -, Pack: 1 |
Hospira UK Ltd., Обединено Кралство |
Hospira Enterprises B.V., Нидерландия |
160.91 |
32.18 |
193.09 |
4% |
6.44 |
167.35 |
33.47 |
200.82 |
16% |
25 |
192.35 |
38.47 |
230.82 |
НСР-3416/30.04.2014 |
22.05.2014 |
22.05.2014 |
|
|
Активен |
8828 |
| Zoledronic acid |
20120592 |
Zoledronic acid Sandoz, Concentrate for solution for infusion, 4mg/5ml, mg, Pack: 1 |
Sandoz d.d., Словения |
Lek d.d Verovskova 57,1526 Ljubljana, Словения; EBEWE Pharma Ges.m.b.H. Nfg. KG Mondseestrasse 11, A-4866 Unterach, Австрия; Novartis Pharma Gmbh, Roonstrasse 25 und Obere Turnstrasse 8; 90429, Nuernberg, Германия; Lek S.A. Полша |
99.12 |
19.82 |
118.94 |
4% |
3.96 |
103.08 |
20.62 |
123.7 |
16% |
15.86 |
118.94 |
23.79 |
142.73 |
НСР-14573/08.12.2017 |
02.01.2018 |
02.01.2018 |
|
|
Активен |
2794 |
| Zoledronic acid |
20130097 |
Zoledronic acid Sandoz, Solution for infusion, 5 mg/ 100 ml, -, Pack: 1 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d., Словения;Ebewe Pharma Ges.m.b.H.Nfg.KG, Австрия; Novartis Pharma GmbH, Германия |
250.29 |
50.06 |
300.35 |
4% |
10 |
260.29 |
52.06 |
312.35 |
16% |
25 |
285.29 |
57.06 |
342.35 |
НСР-2758/17.02.2014 |
06.03.2014 |
06.03.2014 |
Цената се заличава с решение НСР-3569/23.05.2014 |
|
Заличен |
8752 |
| Zolpidem |
20060567 |
Zolsana, Film coated tablet, 5 mg, -, Pack: 20 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
3.07 |
0.61 |
3.68 |
7% |
0.21 |
3.28 |
0.66 |
3.94 |
20% |
0.61 |
3.89 |
0.78 |
4.67 |
НСР-954/12.08.2013 |
01.10.2013 |
01.10.2013 |
|
|
Активен |
8428 |
| Zolpidem |
20060568 |
Zolsana, Film coated tablet, 10 mg, -, Pack: 20 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
3.07 |
0.61 |
3.68 |
7% |
0.21 |
3.28 |
0.66 |
3.94 |
20% |
0.61 |
3.89 |
0.78 |
4.67 |
НСР-954/12.08.2013 |
01.10.2013 |
01.10.2013 |
|
|
Активен |
8429 |
| Zopiclone |
20010133 |
Zopiclon - Takeda, Film coated tablet, 7,5 mg, -, Pack: 20 |
Takeda GmbH, Германия |
Takeda Pharma Sp.z.o.o., Полша |
34.4 |
6.88 |
41.28 |
4% |
1.38 |
35.78 |
7.16 |
42.94 |
16% |
5.5 |
41.28 |
8.26 |
49.54 |
НСР-955/12.08.2013 |
18.09.2013 |
18.09.2013 |
|
|
Активен |
8393 |
| Zopiclone |
20010133 |
Zopiclon - Takeda, Film coated tablet, 7,5 mg, -, Pack: 10 |
Takeda GmbH, Германия |
Takeda Pharma Sp.z.o.o., Полша |
19.09 |
3.82 |
22.91 |
6% |
1.15 |
20.24 |
4.05 |
24.29 |
18% |
3.44 |
23.68 |
4.74 |
28.42 |
НСР-955/12.08.2013 |
18.09.2013 |
18.09.2013 |
|
|
Активен |
8392 |
| Simvastatin |
II-2185/29,05,2008 |
ZOSTATIN, Film coated tablet, 40 mg, -, Pack: 28 |
Адифарм ЕАД, България |
Адифарм ЕАД |
25.56 |
5.11 |
30.67 |
6% |
1.53 |
27.09 |
5.42 |
32.51 |
18% |
4.6 |
31.69 |
6.34 |
38.03 |
КЦ-216/
19,09,2008 г. |
22.10.2008 |
22.10.2008 |
|
|
Активен |
7791 |
| Aciclovir |
II-0912/22.10.2007 г. |
ZOVIRAX, Tablet, 200 mg, -, Pack: 25 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline Pharmaceuticals S.A., Poland |
50.01 |
10 |
60.01 |
4% |
2 |
52.01 |
10.4 |
62.41 |
16% |
8 |
60.01 |
12 |
72.01 |
КЦ-114/
23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7005 |
| Aciclovir |
II-16027/01.03.2007 г. |
ZOVIRAX I.V., Powder for solution for infusion, 250 mg, -, Pack: 5 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline Pharmaceuticals S.A., Poland; GlaxoSmithKline S.p.A., Italy; GlaxoSmithKline ЕООД |
159.26 |
31.85 |
191.11 |
4% |
6.37 |
165.63 |
33.13 |
198.76 |
16% |
25 |
190.63 |
38.13 |
228.76 |
КЦ-114/
23,06,2008 г. |
22.07.2008 |
22.07.2008 |
|
|
Активен |
7006 |
| Rabeprazole |
20100685 |
Zulbex, Gastro resistant tablet, 20 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
11.85 |
2.37 |
14.22 |
6% |
0.71 |
12.56 |
2.51 |
15.07 |
18% |
2.13 |
14.69 |
2.94 |
17.63 |
НСР-953/12.08.2013 |
04.09.2013 |
04.09.2013 |
|
|
Активен |
8356 |
| Rabeprazole |
20100684 |
Zulbex, Gastro resistant tablet, 10 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
10.46 |
2.09 |
12.55 |
6% |
0.63 |
11.09 |
2.22 |
13.31 |
18% |
1.88 |
12.97 |
2.59 |
15.56 |
НСР-953/12.08.2013 |
04.09.2013 |
04.09.2013 |
|
|
Активен |
8355 |
| Ceritinib |
EU/1/15/999/001 |
Zykadia, Capsule, hard, 150, mg, Pack: 150 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
8540.01 |
1708 |
10248.01 |
4% |
10 |
8550.01 |
1710 |
10260.01 |
16% |
25 |
8575.01 |
1715 |
10290.01 |
НСР-14273/26.10.2017 |
10.11.2017 |
02.09.2018 |
Промяна на обстоятелствата НСР-16379/02.08.2018 |
|
Активен |
15919 |
| Ceritinib |
EU/1/15/999/001 |
Zykadia, Capsule, hard, 150, mg, Pack: 150 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
8540.01 |
1708 |
10248.01 |
4% |
10 |
8550.01 |
1710 |
10260.01 |
16% |
25 |
8575.01 |
1715 |
10290.01 |
НСР-14273/26.10.2017 |
10.11.2017 |
02.12.2017 |
|
|
Неактивен |
15919 |
| Olanzapine |
EU/1/08/479/001 |
ZYPADHERA, Powder and solvent for prolonged‐release suspension for injection, 210 mg, -, Pack: 1 |
Eli Lilly Nederland B.V, Нидерландия |
Lilly Pharma Fertigung und Distribution GmbH & Co. KG, Germany |
400.95 |
80.19 |
481.14 |
4% |
10 |
410.95 |
82.19 |
493.14 |
16% |
25 |
435.95 |
87.19 |
523.14 |
КЦ-605/
23,02,2009 г. |
20.03.2009 |
20.03.2009 |
|
|
Активен |
7593 |
| Olanzapine |
EU/1/08/479/001 |
ZYPADHERA, прах и разтворител за инжекционна суспензия с удължено освобождаване, 210 mg, -, Pack: 1 |
Eli Lilly Nederland B.V, Нидерландия |
Lilly Pharma Fertigung und Distribution GmbH & Co. KG, Germany |
400.95 |
80.19 |
481.14 |
4% |
10 |
410.95 |
82.19 |
493.14 |
16% |
25 |
435.95 |
87.19 |
523.14 |
КЦ-605/
23,02,2009 г. |
20.03.2009 |
20.03.2009 |
|
|
Неактивен |
7593 |
| Olanzapine |
EU/1/96/022/020 |
ZYPREXA, Tablet, 5 mg, -, Pack: 56 |
Eli Lilly Nederland B.V, Нидерландия |
Lilly S.A.,Spain |
357.23 |
71.45 |
428.68 |
4% |
10 |
367.23 |
73.45 |
440.68 |
16% |
25 |
392.23 |
78.45 |
470.68 |
НСР-8603/24.03.2016;; НСР-12111/27.03.2017 |
02.05.2016 |
02.05.2017 |
|
|
Заличен |
1417 |
| Olanzapine |
EU/1/96/022/020 |
ZYPREXA, Tablet, 5 mg, -, Pack: 56 |
Eli Lilly Nederland B.V, Нидерландия |
Lilly S.A.,Spain |
357.23 |
71.45 |
428.68 |
4% |
10 |
367.23 |
73.45 |
440.68 |
16% |
25 |
392.23 |
78.45 |
470.68 |
НСР-8603/24.03.2016 |
02.05.2016 |
02.05.2016 |
|
|
Неактивен |
1417 |
| Olanzapine |
EU/1/99/125/008 |
ZYPREXA VELOTAB, Orodispersible tablet, 20 mg, -, Pack: 56 |
Eli Lilly Nederland B.V, Нидерландия |
Lilly S.A.,Spain |
1191.35 |
238.27 |
1429.62 |
4% |
10 |
1201.35 |
240.27 |
1441.62 |
16% |
25 |
1226.35 |
245.27 |
1471.62 |
НСР-8602/24.03.2016;; НСР-12112/27.03.2017 |
02.05.2016 |
02.05.2017 |
|
|
Заличен |
1415 |
| Olanzapine |
EU/1/99/125/008 |
ZYPREXA VELOTAB, Orodispersible tablet, 20 mg, -, Pack: 56 |
Eli Lilly Nederland B.V, Нидерландия |
Lilly S.A.,Spain |
1191.35 |
238.27 |
1429.62 |
4% |
10 |
1201.35 |
240.27 |
1441.62 |
16% |
25 |
1226.35 |
245.27 |
1471.62 |
НСР-8602/24.03.2016 |
02.05.2016 |
02.05.2016 |
|
|
Неактивен |
1415 |
| Ziprasidone hydrogensulphate |
№ II - 3200/ 20.10.2008 |
Zypsila, Capsule, hard, 80 mg, -, Pack: 30 |
KRKA, d.d., Словения |
KRKA, d.d. Novo Mesto, Словения |
110.17 |
22.03 |
132.2 |
4% |
4.41 |
114.58 |
22.92 |
137.5 |
16% |
17.63 |
132.21 |
26.44 |
158.65 |
КЦ-2890/06.10.2011 г. |
05.11.2011 |
05.11.2011 |
|
|
Активен |
7929 |